Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has been ranked as the world's best institution for medical and health teaching and research for the ninth consecutive year in the latest Times Higher Education World University Rankings.

Oxford named best for medicine for ninth consecutive year. (Image credits: John Cairns and Fisher Studios) © John Cairns & Fisher Studios

The subject-specific tables for clinical, pre-clinical and health studies follow on from the announcement that Oxford has been ranked the top university in the world by the same publication for the fourth year running. 

Oxford also came in third place for life sciences and seventh place for physical sciences.

The ranking is based on criteria measuring teaching, research, industry income, international outlook and citations, which are combined to provide a comparison of universities worldwide.

Professor Gavin Screaton, Head of the Medical Sciences Division, said: ‘Our extensive research partnerships and collaborations with universities, researchers and industry at home and abroad play a major part in keeping Oxford at the top of the international league tables, as well as helping us to continue to attract and support some of the best scientists and clinicians to work with us.

‘This focus on research directly translates into improved clinical treatments and teaching, helping us to provide better care and treatment for patients, create a better learning experience for students and continue to help researchers to develop their breakthroughs into successful spin-out companies.’

There are around 5,000 full-time equivalent researchers, teachers and staff across the Medical Sciences Division at Oxford, as well as 1,500 graduate and 1,500 undergraduate students.

Among the highlights for the Medical Sciences Division in the past year were the opening of the BioEscalator - a new innovation centre for high-potential, early-stage medical science companies at the Old Road Campus – the opening of a preventative healthcare clinic in London in partnership with Mayo Clinic to drive advances in medical research and patient care, and the award of the Nobel Prize in Physiology or Medicine to Professor Sir Peter Ratcliffe, Director for the Target Discovery Institute within the Nuffield Department of Medicine at Oxford University and Director of Clinical Research at Francis Crick Institute, London. This year also saw the world’s first gene therapy trial for dry age-related macular degeneration (AMD), led at Oxford by Professor Robert MacLaren.

The division is one of the largest biomedical research centres in Europe, carrying out a substantial number of clinical trials to develop new treatments and to improve patient care and safety. Both research and clinical trials are supported by a network of international research units in Africa and Asia, as well as close partnerships with the Oxford University Hospitals and Oxford Health NHS Foundation Trusts. This enables constant improvements to the University's research and teaching, while the latest developments in medical research lead to improved patient care.

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.